102 related articles for article (PubMed ID: 7630180)
1. Interleukin-6 autoantibodies: possible biological and clinical significance.
Hansen MB; Svenson M; Diamant M; Abell K; Bendtzen K
Leukemia; 1995 Jul; 9(7):1113-5. PubMed ID: 7630180
[TBL] [Abstract][Full Text] [Related]
2. Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors.
Hansen MB; Svenson M; Abell K; Yasukawa K; Diamant M; Bendtzen K
Eur J Immunol; 1995 Feb; 25(2):348-54. PubMed ID: 7875195
[TBL] [Abstract][Full Text] [Related]
3. IL-6-anti-IL-6 autoantibody complexes with IL-6 activity in sera from some patients with systemic sclerosis.
Suzuki H; Takemura H; Yoshizaki K; Koishihara Y; Ohsugi Y; Okano A; Akiyama Y; Tojo T; Kishimoto T; Kashiwagi H
J Immunol; 1994 Jan; 152(2):935-42. PubMed ID: 8283060
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 chaperones in blood.
May LT; Ndubuisi MI; Patel K; García D
Ann N Y Acad Sci; 1995 Jul; 762():120-8. PubMed ID: 7668523
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
Hirano T; Matsuda T; Nakajima K
Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
[TBL] [Abstract][Full Text] [Related]
6. Transfusion-related inhibition of cytokines (TRICK). Experimental transfer of neutralizing autoantibodies to interleukin-6 by plasma transfusions.
Hansen MB; Galle P; Salomo M; Svenson M; Dickmeiss E; Gimsing P
Vox Sang; 2007 Apr; 92(3):213-23. PubMed ID: 17348870
[TBL] [Abstract][Full Text] [Related]
7. Characterization and potential clinical applications of autoantibodies against cytokines.
de Lemos Rieper C; Galle P; Hansen MB
Cytokine Growth Factor Rev; 2009 Feb; 20(1):61-75. PubMed ID: 19213592
[TBL] [Abstract][Full Text] [Related]
8. [Basic and clinical aspects of IL-6].
Nakajima K; Hirano T
Gan To Kagaku Ryoho; 1991 Apr; 18(4):505-14. PubMed ID: 1707253
[TBL] [Abstract][Full Text] [Related]
9. Binding of cytokines to pharmaceutically prepared human immunoglobulin.
Svenson M; Hansen MB; Bendtzen K
J Clin Invest; 1993 Nov; 92(5):2533-9. PubMed ID: 8227366
[TBL] [Abstract][Full Text] [Related]
10. High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors.
Galle P; Svenson M; Bendtzen K; Hansen MB
Eur J Immunol; 2004 Nov; 34(11):3267-75. PubMed ID: 15368270
[TBL] [Abstract][Full Text] [Related]
11. Plasticity and cross-talk of interleukin 6-type cytokines.
Garbers C; Hermanns HM; Schaper F; Müller-Newen G; Grötzinger J; Rose-John S; Scheller J
Cytokine Growth Factor Rev; 2012 Jun; 23(3):85-97. PubMed ID: 22595692
[TBL] [Abstract][Full Text] [Related]
12. Receptors for interleukin 4, interleukin 5 and interleukin 6.
Banchereau J; Galizzi JP
Ann Ist Super Sanita; 1990; 26(3-4):453-67. PubMed ID: 2091506
[TBL] [Abstract][Full Text] [Related]
13. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and autoantibodies to cytokines.
Bendtzen K; Hansen MB; Ross C; Poulsen LK; Svenson M
Stem Cells; 1995 May; 13(3):206-22. PubMed ID: 7613489
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury.
Davies AL; Hayes KC; Dekaban GA
Arch Phys Med Rehabil; 2007 Nov; 88(11):1384-93. PubMed ID: 17964877
[TBL] [Abstract][Full Text] [Related]
16. The biological role of naturally-occurring cytokine inhibitors.
Arend WP; Malyak M; Bigler CF; Smith MF; Janson RW
Br J Rheumatol; 1991; 30 Suppl 2():49-52. PubMed ID: 1847086
[TBL] [Abstract][Full Text] [Related]
17. Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist.
Ciapponi L; Maione D; Scoumanne A; Costa P; Hansen MB; Svenson M; Bendtzen K; Alonzi T; Paonessa G; Cortese R; Ciliberto G; Savino R
Nat Biotechnol; 1997 Oct; 15(10):997-1001. PubMed ID: 9335053
[TBL] [Abstract][Full Text] [Related]
18. Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
Heinrich PC; Behrmann I; Haan S; Hermanns HM; Müller-Newen G; Schaper F
Biochem J; 2003 Aug; 374(Pt 1):1-20. PubMed ID: 12773095
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens.
Biet F; Locht C; Kremer L
J Mol Med (Berl); 2002 Mar; 80(3):147-62. PubMed ID: 11894141
[TBL] [Abstract][Full Text] [Related]
20. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
